← Back to Search

Community Support & Education for Opioid Use Disorder (CENS Trial)

N/A

Recruiting

Led By Alexander S Bennett, PhD

Research Sponsored by New York University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Adult (18+) age

Be older than 18 years old

Must not have

Unable to speak English

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 9 months follow-up assesment

Awards & highlights

No Placebo-Only Group

Summary

This trial evaluates an intervention to reduce opioid-related risk behaviors in veterans with opioid use disorder. It involves peer outreach workers, educational sessions, healthcare navigation & social support. Findings will benefit community & civic healthcare orgs that provide overdose/HIV risk reduction.

Who is the study for?

This trial is for adult veterans with any severity of opioid use disorder who currently misuse opioids and are not connected to VA healthcare. Participants must be able to speak English and provide informed consent.

What is being tested?

The study tests a peer-delivered, community-based education, navigation, and support intervention aimed at reducing opioid-related risks among veterans. It includes overdose education, safer substance use knowledge, treatment guidance, social service navigation, and peer support.

What are the potential side effects?

Since the interventions involve educational sessions and social support rather than medical treatments or drugs, there are no direct side effects like those associated with medications.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I cannot speak English.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 9 months follow-up assesment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~9 months follow-up assesment

This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 months follow-up assesment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in HIV/HCV Risk Behaviors

Change in Opioid Overdose Risk Behaviors Scale

Secondary study objectives

Drug Treatment

HIV/HCV Testing

Health service utilization

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: ControlExperimental Treatment1 Intervention

Participants will receive Overdose Education and Naloxone and referrals to treatment

Group II: CENS InterventionExperimental Treatment4 Interventions

Peer outreach workers will deliver Overdose Education and Naloxone to participants and provide education, navigation, and support during the 9-month intervention

0 / 2Eligibility criteria met